Exogenous lactate

Exogenous lactate
Exogenous L-lactate
CH₃CH(OH)COO-
Identification
Other names Exogenous lactate; oral L-lactate; lactate supplement; exolactate; exo lactate
Active ion L-lactate (S-2-hydroxypropanoate)
Common salts Sodium L-lactate, calcium L-lactate, magnesium L-lactate
Emerging forms Lactate esters; hydrogel formulations; encapsulated lactate
Physiology
Absorption Intestinal monocarboxylate transporters (mainly MCT1)
Cellular uptake MCT1 (oxidative tissues); MCT4 (efflux from glycolytic tissues)
Metabolic fate Pyruvate via lactate dehydrogenase → TCA cycle; gluconeogenic substrate
Reported intake range ≈10–25 g·h⁻¹ (proposed for endurance)
Use
Field Sports nutrition; metabolic and clinical research
Status Investigational; not on any anti-doping prohibited list

Exogenous lactate, sometimes referred to as Exolactate, is L-lactate that is supplied to the body from an external source, typically as an oral supplement or, in research and medical settings, by intravenous infusion. It has been investigated as a potential ergogenic aid in endurance sports, as a recovery substrate and as a metabolic intervention in clinical contexts such as traumatic brain injury and metabolic disease.

Leading researchers in this field include scientists such as George Brooks, L. Bruce Gladden, Joshua Rabinowitz, Inigo San Millán and Sheng Tony Hui.

Lactate has been historically described as a waste product, associated with muscle fatigue and acidosis. The lactate shuttle theory, developed primarily by George A. Brooks during the 1980s and 1990s, reframed lactate as a circulating energy substrate that is exchanged between glycolytic and oxidative tissues, whilst also acting as a signalling molecule. Within this framework, lactate produced in one tissue can be oxidised in another via monocarboxylate transporters (MCTs).

Most circulating lactate is produced endogenously (within the body), however humans can also absorb lactate from the gut. Exogenous lactate enters systemic circulation through intestinal MCTs, predominantly MCT1, whereupon it is rapidly converted to pyruvate by lactate dehydrogenase, before entering the tricarboxylic acid (TCA) cycle in mitochondria.

Researchers have proposed that, provided it is delivered safely and at sufficient rates (10–25 g per hour), exogenous lactate could complement carbohydrate-based fuelling during prolonged endurance exercise. Hypothesised to be possible due to the intestinal absorption of lactate using transporters independent of those used by glucose and fructose.